1. Feasibility, acceptability and safety of downhill walking during pulmonary rehabilitation for patients with COPD: Results from a randomised controlled trial
- Author
-
Thierry Troosters, Christian R. Osadnik, Fernanda M.M. Rodrigues, Wim Janssens, Matthias Loeckx, Chris Burtin, Miek Hornikx, Heleen Demeyer, and Carlos Augusto Camillo
- Subjects
COPD ,medicine.medical_specialty ,Muscle fatigue ,business.industry ,Incidence (epidemiology) ,medicine.medical_treatment ,medicine.disease ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,030228 respiratory system ,Randomized controlled trial ,Femoral nerve ,law ,medicine ,Physical therapy ,Pulmonary rehabilitation ,030212 general & internal medicine ,Tendinopathy ,Adverse effect ,business - Abstract
Background: Downhill walking (DW) enhances quadriceps contractile muscle fatigue (CMF) with less symptoms than level walking (LW) in patients with COPD. Its use in clinical practice is limited by a lack of data regarding efficacy, acceptability and safety. Aim: To determine the feasibility, acceptability and safety of DW as part of pulmonary rehabilitation (PR) in patients with COPD. Methods: 39 COPD patients (62±9yrs; FEV 1 49±17%pred) were randomised to PR with DW or LW. CMF was assessed via magnetic femoral nerve stimulation at week 2 & 12. Feasibility was defined as protocol completion >75% DW patients. Acceptability was assessed via surveys, and safety via incidence of adverse events and serum creatine kinase (CK) levels at weeks 0, 2, 6 & 12. Training progression was analysed weekly. Results: The table shows development of CMF was maintained in DW more than LW. In DW, protocol completion rate was high (attrition unrelated to training) and adverse events rare (mild tendinopathy). CK levels were lower in DW compared to LW (p Conclusion: DW as part of PR is feasible, acceptable, safe and enhances training progression more than LW. These data support the use of DW in exercise training programs for COPD.
- Published
- 2016